ALMS (Alumis) Other Financing: $23.94 Mil (TTM As of Mar. 2026)


ALMS Alumis Inc ALMS
12 GF Score
Price $25.05
! 4 Warning Signs
View Full Analysis

What is Alumis Other Financing?

Alumis ALMS +0.12% 12 Other Financing is $23.94 Mil as of Mar. 2026. GuruFocus rates ALMS with a GF Score™ of 12/100. The stock has 4 warning signs investors should review.

Alumis's Other Financing for the three months ended in Mar. 2026 was $23.19 Mil.

Alumis's Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 was $23.94 Mil.

Alumis Other Financing Historical Data

* Premium members only.

The historical data trend for Alumis's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alumis Other Financing Chart

Alumis Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Other Financing
1.73 -0.10 40.59 0.00

Alumis Quarterly Data
Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.75 0.00 23.19
ALMS
12GF Score
Alumis Inc ALMS
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alumis Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $23.94 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of $23.94 Mil mean?
Alumis (ALMS) has a Other Financing of $23.94 Mil as of Mar. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Alumis and its competitors.
Is Alumis' Other Financing too high?
Alumis' current Other Financing is $23.94 Mil. Overall, Alumis has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Alumis' Other Financing compare to SLNO and ARQT?
Alumis' Other Financing of $23.94 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Biotechnology company?
A good Other Financing depends on the Biotechnology industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Alumis and its competitors. Alumis's current Other Financing is $23.94 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alumis stock overvalued right now?
Alumis (ALMS) has a current Other Financing of $23.94 Mil. The current Other Financing is $23.94 Mil. Alumis' overall GF Score™ is 12/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Alumis (ALMS), the current Other Financing is $23.94 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Alumis Business Description

Address 280 East Grand Avenue, South San Francisco, CA, USA, 94080
Alumis Inc is a clinical-stage biopharmaceutical company with an initial focus on developing its two Tyrosine Kinase 2 ("TYK2") inhibitors: envudeucitinib ("envu"), an allosteric TYK2 inhibitor for the treatment of PsO and SLE; and A-005, a central nervous system ("CNS") penetrant allosteric TYK2 inhibitor, to offer the therapeutic benefit of TYK2 inhibition within the CNS for a broad range of neuroinflammatory and neurodegenerative diseases.
12GF Score

Get the complete analysis for ALMS

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$25.05
Price